EFNB1 Acts as a Novel Prognosis Marker in Glioblastoma through Bioinformatics Methods and Experimental Validation

Figure 7

Construction of a risk model based on EFNB1-associated immunomodulators. (a) LASSO plot was created by the lambda sequence. (b) LASSO coefficient profiling of four genes. (c) Forest plot exhibiting the prognostic power of signature genes.

(a)

(b)

(c)